A diagnostic product utilizing GeneCker's ultra-precision CRISPR/Cas9 technology for genetic analysis. Part of GeneCker's one-stop cancer diagnosis platform that includes sample collection, DNA sequencing, and data output capabilities.
Manufactured by
Seoul, South Korea
GeneCker is a biotechnology company specializing in ultra-precision CRISPR technology and the MUTE-Seq® platform—an ultrasensitive liquid-biopsy NGS solution. From research and development to kit manufacturing, we provide an end-to-end service for advanced cancer genomics. Our flagship CRISPincette MultiCancer kit incorporates both our patented MUTE-Seq® and CRISPR Cas9 technologies to enrich variant-containing DNA fragments for accurate multi-cancer risk assessment. With operations in Korea, China, and other global markets, GeneCker delivers solutions for Multi-Cancer Early Detection (MCED) and Minimal Residual Disease (MRD) monitoring at ~20× higher analytical precision and one-tenth the per-sample cost compared to conventional UMI-based NGS.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Intelligenome
United States · 3 relevant products
Beijing SynsorBio Technology Co., Ltd
China · 3 relevant products
Guangzhou magigen biotechnology Co.,Ltd
China · 9 relevant products
Genomtec S.A.
Poland · 1 relevant product
HealthTec Logix
Kuwait · 2 relevant products
Wuhan YZY Medical Science and Technology Co.,Ltd.
China · 2 relevant products
Beijing Jianping Jinxing Biomedical Co., Ltd
China · 1 relevant product
HymonBio Co., Ltd.
China · 1 relevant product
Hicomp Microtech(Suzhou) Co., Ltd.
China · 1 relevant product
GENETRON HEALTH (BEIJING) CO., LTD
China · 3 relevant products
32 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →5 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 66 closest product alternatives
Intelligenome · United States
CRISPR-based diagnostic assay for oncology applications. Provides molecular detection and monitoring capabilities for cancer-related diagnostics.
Beijing SynsorBio Technology Co., Ltd · China
CRISPR-based molecular diagnostic test for tumor detection utilizing proprietary isothermal amplification and microfluidic integration. Enables rapid point-of-care testing with high sensitivity and specificity for oncology screening and monitoring applications.
Guangzhou magigen biotechnology Co.,Ltd · China
Cas9 protein that recognizes and cleaves DNA molecules for gene editing and gene therapy applications. Widely used in molecular diagnostics and genetic engineering.
Intelligenome · United States
IntelliGenome's proprietary CRISPR technology platform for decentralized diagnostics. Accurately detects pathogens and monitors treatment response across multiple applications including TB and oncology.
Guangzhou magigen biotechnology Co.,Ltd · China
High-efficiency CRISPR/Cas12Ultra gene editing tool with independent patent protection for gene therapy applications including CAR-T cell therapy. Advanced molecular diagnostic and therapeutic tool.
Beijing SynsorBio Technology Co., Ltd · China
Single-target CRISPR detection device for point-of-care testing applications. Integrates CRISPR-based molecular detection with microfluidics technology to enable rapid, accurate identification of specific nucleic acid targets in clinical specimens. Designed for decentralized diagnostic workflows requiring minimal infrastructure.
Genomtec S.A. · Poland
An early-stage genetic diagnostic test platform designed for tumor-related genetic analysis and molecular profiling. The product is currently in development for point-of-care oncology applications.
HealthTec Logix · Kuwait
Comprehensive genomic diagnostic platform providing precision analysis for disease detection and personalized treatment planning. Integrates molecular-based technologies with clinical interpretation for accurate patient stratification.
Beijing SynsorBio Technology Co., Ltd · China
A point-of-care testing system utilizing CRISPR technology for rapid nucleic acid detection. The system integrates microfluidics and synthetic biology for accurate identification of genetic sequences in clinical samples.
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
Molecular diagnostic kit for genetic testing and variant detection. Supports precision medicine applications in cardiovascular and oncology disease management.
Guangzhou magigen biotechnology Co.,Ltd · China
Patented high-efficiency gene editing tool enzyme for molecular detection and gene therapy applications including CAR-T cell development.
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
Diagnostic kit for analyzing cancer-related genetic mutations and biomarkers. Provides genomic information to support targeted therapy selection and treatment planning.
54 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products